MedAssets (MDAS +1.8%) moves up on an upgrade to Buy at UBS, saying the company's RCM segment...

|By:, SA News Editor

MedAssets (MDAS +1.8%) moves up on an upgrade to Buy at UBS, saying the company's RCM segment growth will accelerate, and when combined with SCM execution it should drive shares higher. The firm raises its price target to $18 from $14.